ArticleJournal of imaging2025
Multi-Class Classification of Breast Cancer Subtypes Using ResNet Architectures on Histopathological Images.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Automated detection of giant cell arteritis from temporal artery biopsy specimens using deep learning approaches.Scientific reports · 2026Article
- Cross-Architecture Knowledge Distillation for Histopathological Image Analysis.IEEE access : practical innovations, open solutions · 2026Article
- Automated breast cancer diagnosis via intensity-guided contour segmentation and ResNet-based classification using local intensity pattern tensors.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a significant cause of cancer-related mortality among women around the globe, underscoring the need for early and accurate diagnosis. Typically, histopathological analysis of biopsy slides is utilized for tumor classification. However, it is labor-intensive, subjective, and often affected by inter-observer variability. Therefore, this study explores a deep learning-based, multi-class classification framework for distinguishing breast cancer subtypes using convolutional neural networks (CNNs). Unlike previous work using the popular BreaKHis dataset, where binary classification models were applied, in this work, we differentiate eight histopathological subtypes: four benign (adenosis, fibroadenoma, phyllodes tumor, and tubular adenoma) and four malignant (ductal carcinoma, lobular carcinoma, mucinous carcinoma, and papillary carcinoma). This work leverages transfer learning with ImageNet-pretrained ResNet architectures (ResNet-18, ResNet-34, and ResNet-50) and extensive data augmentation to enhance classification accuracy and robustness across magnifications. Among the ResNet models, ResNet-50 achieved the best performance, attaining a maximum accuracy of 92.42%, an AUC-ROC of 99.86%, and an average specificity of 98.61%. These findings validate the combined effectiveness of CNNs and transfer learning in capturing fine-grained histopathological features required for accurate breast cancer subtype classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.